On August 2, 2016, ALJ Theodore R. Essex issued Order No. 5 in Certain L-Tryptophan, L-Tryptophan Products, and Their Methods of Production (Inv. No. 337-TA-1005).

By way of background, this investigation is based on a May 10, 2016 complaint filed by Ajinomoto Co., Inc. and Ajinomoto Heartland Inc. alleging violation of Section 337 by way of unlawful importation into the U.S., selling for importation, and/or selling within the U.S. after importation certain L-tryptophan and L-tryptophan products that infringe one or more claims of U.S. Patent Nos. 7,666,655 and 6,180,373. See our May 10, 2016 and June 13, 2016 posts for more details on the complaint and Notice of Investigation, respectively.

According to Order No. 5, ALJ Essex set the procedural schedule. Specifically, ALJ Essex set the evidentiary hearing to commence on March 6, 2017 and end on March 10, 2017. Additionally, ALJ Essex determined that the initial determination on violation shall be issued no later than June 16, 2017.